Stryker Total Long-Term Assets 2010-2024 | SYK

Stryker total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Stryker total long-term assets for the quarter ending September 30, 2024 were $29.160B, a 8.01% increase year-over-year.
  • Stryker total long-term assets for 2023 were $27.394B, a 2.95% increase from 2022.
  • Stryker total long-term assets for 2022 were $26.609B, a 8.11% increase from 2021.
  • Stryker total long-term assets for 2021 were $24.614B, a 0.04% decline from 2020.
Stryker Annual Total Long-Term Assets
(Millions of US $)
2023 $27,394
2022 $26,609
2021 $24,614
2020 $24,623
2019 $19,109
2018 $17,496
2017 $14,204
2016 $12,574
2015 $8,280
2014 $8,595
2013 $7,408
2012 $5,058
2011 $4,939
2010 $3,263
2009 $3,220
Stryker Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $29,160
2024-06-30 $27,485
2024-03-31 $27,510
2023-12-31 $27,394
2023-09-30 $26,997
2023-06-30 $27,258
2023-03-31 $26,675
2022-12-31 $26,609
2022-09-30 $26,665
2022-06-30 $27,207
2022-03-31 $27,412
2021-12-31 $24,614
2021-09-30 $24,685
2021-06-30 $24,666
2021-03-31 $24,476
2020-12-31 $24,623
2020-09-30 $18,741
2020-06-30 $18,682
2020-03-31 $18,704
2019-12-31 $19,109
2019-09-30 $18,093
2019-06-30 $18,169
2019-03-31 $18,049
2018-12-31 $17,496
2018-09-30 $14,166
2018-06-30 $14,157
2018-03-31 $14,282
2017-12-31 $14,204
2017-09-30 $13,775
2017-06-30 $12,814
2017-03-31 $12,628
2016-12-31 $12,574
2016-09-30 $12,821
2016-06-30 $12,696
2016-03-31 $8,343
2015-12-31 $8,280
2015-09-30 $7,884
2015-06-30 $7,883
2015-03-31 $7,853
2014-12-31 $8,595
2014-09-30 $8,189
2014-06-30 $7,848
2014-03-31 $7,713
2013-12-31 $7,408
2013-09-30 $5,696
2013-06-30 $5,693
2013-03-31 $5,668
2012-12-31 $5,058
2012-09-30 $5,137
2012-06-30 $5,064
2012-03-31 $5,230
2011-12-31 $4,939
2011-09-30 $5,152
2011-06-30 $5,094
2011-03-31 $4,730
2010-12-31 $3,263
2010-09-30 $3,228
2010-06-30 $3,160
2010-03-31 $3,223
2009-12-31 $3,220
2009-09-30 $2,697
2009-06-30 $2,683
2009-03-31 $2,585
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $146.711B $20.498B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.249B 26.05
Boston Scientific (BSX) United States $132.644B 38.14
EssilorLuxottica (ESLOY) France $112.106B 0.00
Medtronic (MDT) Ireland $110.562B 16.42
Haleon (HLN) United Kingdom $43.682B 28.38
Lonza Group Ag (LZAGY) Switzerland $42.166B 0.00
GE HealthCare Technologies (GEHC) United States $37.665B 19.54
ResMed (RMD) United States $35.786B 29.41
Terumo (TRUMY) Japan $29.739B 0.00
Koninklijke Philips (PHG) Netherlands $24.805B 18.99
Zimmer Biomet Holdings (ZBH) United States $21.942B 13.97
Insulet (PODD) United States $18.443B 73.44
Baxter (BAX) United States $16.957B 11.03
Smith & Nephew SNATS (SNN) United Kingdom $11.065B 0.00
BellRing Brands (BRBR) United States $10.158B 40.72
Bio-Rad Laboratories (BIO) United States $9.320B 31.68
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $6.294B 14.62
TG Therapeutics (TGTX) United States $5.459B 0.00
Haemonetics (HAE) United States $4.297B 20.97
Prestige Consumer Healthcare (PBH) United States $4.192B 20.85
ICU Medical (ICUI) United States $4.125B 39.27
Perrigo (PRGO) Ireland $3.830B 11.27
Envista Holdings (NVST) United States $3.697B 27.54
Neogen (NEOG) United States $3.246B 37.45
Agios Pharmaceuticals (AGIO) United States $3.175B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.841B 18.22
QuidelOrtho (QDEL) United States $2.700B 17.38
LeMaitre Vascular (LMAT) United States $2.428B 59.00
Warby Parker (WRBY) United States $2.349B 0.00
Green Thumb Industries (GTBIF) United States $1.913B 33.48
AtriCure (ATRC) United States $1.742B 0.00
InMode (INMD) Israel $1.597B 9.61
AdaptHealth (AHCO) United States $1.326B 9.48
Maravai LifeSciences Holdings (MRVI) United States $1.318B 0.00
Curaleaf Holdings (CURLF) Canada $1.267B 0.00
BioLife Solutions (BLFS) United States $1.207B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.96
Owens & Minor (OMI) United States $0.952B 7.44
CeriBell (CBLL) United States $0.943B 0.00
National Vision Holdings (EYE) United States $0.918B 30.68
Capricor Therapeutics (CAPR) United States $0.847B 0.00
Evolus (EOLS) United States $0.798B 0.00
VAREX IMAGING (VREX) United States $0.684B 30.25
Omeros (OMER) United States $0.632B 0.00
Surmodics (SRDX) United States $0.563B 0.00
Cresco Labs (CRLBF) United States $0.533B 0.00
Verano Holdings (VRNOF) United States $0.522B 0.00
Canopy Growth (CGC) Canada $0.468B 0.00
Quanterix (QTRX) United States $0.451B 0.00
ZimVie (ZIMV) United States $0.391B 32.95
Valneva SE (VALN) France $0.360B 0.00
Viemed Healthcare (VMD) United States $0.341B 32.41
Cerus (CERS) United States $0.332B 0.00
Sanara MedTech (SMTI) United States $0.330B 0.00
Biote (BTMD) United States $0.325B 7.12
OraSure Technologies (OSUR) United States $0.289B 19.40
Zynex (ZYXI) United States $0.263B 55.07
Aurora Cannabis (ACB) Canada $0.238B 0.00
TerrAscend (TSNDF) Canada $0.225B 0.00
Utah Medical Products (UTMD) United States $0.221B 15.29
High Tide (HITI) Canada $0.213B 88.33
MacroGenics (MGNX) United States $0.203B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.167B 100.00
Organigram Holdings (OGI) Canada $0.166B 0.00
Jin Medical (ZJYL) China $0.164B 0.00
Zevia PBC (ZVIA) United States $0.160B 0.00
FitLife Brands (FTLF) United States $0.149B 18.67
TriSalus Life Sciences (TLSI) United States $0.138B 0.00
Fonar (FONR) United States $0.104B 11.74
Quipt Home Medical (QIPT) United States $0.104B 0.00
Veru (VERU) United States $0.099B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.40
Ayr Wellness (AYRWF) United States $0.077B 0.00
Rockwell Medical (RMTI) United States $0.073B 37.50
Exagen (XGN) United States $0.072B 0.00
Cellectar Biosciences (CLRB) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.062B 0.00
Modular Medical (MODD) United States $0.058B 0.00
MariMed (MRMD) United States $0.057B 0.00
Apyx Medical (APYX) United States $0.054B 0.00
Safety Shot (SHOT) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.019B 0.00
Meihua Medical Technologies (MHUA) China $0.018B 0.00
Innovative Eyewear (LUCY) United States $0.016B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.002B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.83
SNDL (SNDL) Canada $0.000B 0.00